Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CGEN stock hub

Compugen Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

274.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CGEN

In the news

Latest news · CGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E7.7

P25 14.9P50 23.2P75 38.5

ROE44.8

P25 -105.6P50 -46.5P75 -3.1

ROIC23.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001119774
Company name	Compugen Ltd.
Country	Israel
Country code	US
Cusip	M25722105
Employees	75
Employees Change	1%
Employees Change Percent	1.35
Enterprise value	$131.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-08-11
Isin	IL0010852080
Last refreshed	2026-05-10
Market cap	$274.2M
Market cap category	Micro-Cap
Price	$2.9
Price currency	USD
Rev Per Employee	970,186.67x
Sector	Healthcare
Sic	2836
Symbol	CGEN
Website	https://cgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.89%
EV Earnings	3.72x
EV Sales Forward	8.82x
EV/EBIT	4.2x
EV/EBITDA	4.14x
EV/FCF	4.2x
EV/Sales	1.81x
FCF yield	11.42%
P/B ratio	2.67x
P/E ratio	7.67x
P/S ratio	3.77x
PS Forward	18.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	43.05%
EBITDA Margin	43.7%
FCF margin	43.05%
Gross margin	87.29%
Gross Profit	$63.5M
Gross Profit Growth	218.62%
Gross Profit Growth Q	7,914.57%
Gross Profit Growth3 Y	113.51%
Gross Profit Growth5 Y	100.91%
Net Income	$35.3M
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Pretax Margin	48.65%
Profit Margin	48.57%
Profit Per Employee	$471,240
Profitable Years	1
ROA	14.42
Roa5y	-7.35
ROCE	23.38
ROE	44.84
Roe5y	-14.35
ROIC	23.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.7%
Cagr15y	-3.25%
Cagr1y	132.13%
Cagr20y	-1.52%
Cagr3y	66.33%
Cagr5y	-17.5%
EPS Growth Quarters	1
EPS Growth Years	4
FCF Growth	-36.69%
OCF Growth	-36.23%
Revenue Growth	161.14x
Revenue Growth Q	4,477.29x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	113.28x
Revenue Growth5 Y	105.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$156.6M
Cash	$145.6M
Current Assets	$148M
Current Liabilities	$22.6M
Debt	$3M
Debt EBITDA	$0.09
Debt Equity	$0.03
Debt FCF	$0.09
Equity	$102.7M
Liabilities	$53.8M
Long Term Assets	$8.5M
Long Term Liabilities	$31.3M
Net Cash	$142.7M
Net Cash By Market Cap	$52.03
Net Cash Growth	42.19%
Net Debt EBITDA	$-4.49
Net Debt Equity	$-1.39
Net Debt FCF	$-4.55
Tangible Book Value	$102.7M
Tangible Book Value Per Share	$1.09
WACC	19.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.56
Net Working Capital	$-19.7M
Quick ratio	6.46
Working Capital	$125.5M
Working Capital Turnover	$0.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.79%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-55.11%
1Y total return	132%
200-day SMA	1.83
3Y total return	360.32%
50-day SMA	2.43
50-day SMA vs 200-day SMA	50over200
5Y total return	-61.77%
All Time High	19.9
All Time High Change	-85.43%
All Time High Date	2020-08-26
All Time Low	0.34
All Time Low Change	752.94%
All Time Low Date	2008-11-24
ATR	0.16
Beta	2.8
Beta1y	1.18
Beta2y	1.37
Ch YTD	89.54
High	2.95
High52	3.24
High52 Date	2026-04-24
High52ch	-10.36%
Low	2.83
Low52	1.25
Low52 Date	2025-05-08
Low52ch	132%
Ma50ch	19.44%
Premarket Change Percent	0.7
Premarket Price	$2.88
Premarket Volume	4,794
Price vs 200-day SMA	58.3%
RSI	61.5
RSI Monthly	63.12
RSI Weekly	65.96
Sharpe ratio	1.48x
Sortino ratio	2.95
Total Return	-4.79%
Tr YTD	89.54
Tr15y	-39.08%
Tr1m	25%
Tr1w	7.01%
Tr3m	73.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	1,529,760x
Earnings Revenue Estimate Growth	-33.02x
Operating Income	$31.3M
Operating margin	43.05
Price target	$5
Price Target Change	$72.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	92,414,057%
Float Percent	97.74%
Shares Insiders	0.32%
Shares Institutions	13.6%
Shares Out	94,554,127
Shares Qo Q	0.82%
Shares Yo Y	4.79%
Short Ratio	3.31
Short Shares	1.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$29.4M
Average Volume	569,796.7x
Bv Per Share	1.09
CAPEX	$-306,000
Ch10y	-55.11
Ch15y	-39.08
Ch1m	25
Ch1w	7.01
Ch1y	132
Ch20y	-26.4
Ch3m	73.65
Ch3y	360.3
Ch5y	-61.77
Ch6m	79.01
Change	1.4%
Change From Open	0
Close	2.86
Days Gap	1.4
Depreciation Amortization	475,000
Dollar Volume	979,524.3
Earnings Date	2026-05-18
Earnings Time	bmo
EBIT	$31.3M
EBITDA	$31.8M
EPS	$0.38
F Score	6
FCF	$31.3M
FCF EV Yield	23.82x
FCF Per Share	$0.33
Financing CF	10,604,000
Fiscal Year End	December
Founded	1,993
Graham Number	3.04105
Graham Upside	4.86
Income Tax	$54,000
Investing CF	29,995,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	1.96
Ma150ch	47.96%
Ma20	2.82
Ma20ch	2.98%
Net CF	72,368,000
Next Earnings Date	2026-05-18
Open	2.9
Optionable	Yes
P FCF Ratio	8.75
P OCF Ratio	8.67
Position In Range	60
Post Close	2.9
Postmarket Change Percent	1.12
Postmarket Price	$2.93
Ppne	3,202,000
Pre Close	2.86
Price Date	2026-05-08
Price EBITDA	$8.62
Ptbv Ratio	2.67
Relative Volume	0.59x
Revenue	72,764,000x
SBC By Revenue	2.59x
Share Based Comp	1,881,000
Tax By Revenue	0.07x
Tax Rate	0.15%
Tr20y	-26.4%
Tr6m	79.01%
Volume	337,767
Z Score	-0.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CGEN pay a dividend?

Capital-return profile for this ticker.

Performance

CGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.6%

Float: +97.7% of shares outstanding

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.5

Neutral momentum band

Price vs 200-day MA

+58.3%

50/200-day relationship not available

Beta (5Y)

2.80

More volatile than the market

Sharpe ratio

1.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CGEN stock rating?

Compugen Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CGEN analysis?

The full report lives at /stocks/CGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CGEN?

The latest report frames CGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.